UCLA Health is conducting two clinical trials to evaluate antibody-drug conjugates (ADCs) for targeted ovarian cancer therapy, aiming to enhance treatment efficacy and reduce side effects by delivering chemotherapy directly to tumor cells.
follow.it gives you an easy way to subscribe to Mlo-online__rsswebsite-scheduled-content's news feed! Click on Follow below and we deliver the updates you want via email, phone or you can read them here on the website on your own news page.
You can also unsubscribe anytime painlessly. You can even combine feeds from Mlo-online__rsswebsite-scheduled-content with other site's feeds!
Title: Home | MLO Online